Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-04
2009-10-13
Coleman, Brenda L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S281000
Reexamination Certificate
active
07601724
ABSTRACT:
In its many embodiments, the present invention provides a class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases (CDKs), methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions. An illustrative compound of the invention is shown below:
REFERENCES:
Wolff, Manfred E. “Burger's Medicinal Chemistry, 5ed, Part I”, John Wiley & Sons, 1995, pp. 975-977.
Banker, G.S. et al, “Modern Pharmaceutics, 3ed.”, Marcel Dekker, New York, 1996, pp. 451 and 596.
Vippagunta et. al., Advanced Drug Delivery, 2001,, 48, 3-26.
Dwyer Michael P.
Guzi Timothy J.
Paruch Kamil
Coleman Brenda L
Kalyanaraman Palaiyur S.
Moore Susanna
Schering Corporation
LandOfFree
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrazolo[1,5-a]pyrimidines as protein kinase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrazolo[1,5-a]pyrimidines as protein kinase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4063815